Skip to main content

Table 3 Dimension responses for EQ-3D-3L and EQ-3D-5L across eight patient groups and a student cohort

From: Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study

  Level Mobility Self-Care Usual Activities Pain/Discomfort Anxiety/Depression
3L 5L 3L 5L 3L 5L 3L 5L 3L 5L
N % N % N % N % N % N % N % N % N % N %
Cardiovascular disease 1 70 28 56 22 145 58 136 54 75 30 64 25 74 29 64 25 126 50 110 44
2 179 71 60 24 94 37 61 24 135 54 57 23 151 60 71 28 111 44 70 28
3 2 1 74 29 12 5 35 14 41 16 67 27 26 10 61 24 14 6 51 20
4 – – 56 22 – – 12 5 – – 42 17 – – 45 18 – – 14 6
5 – – 5 2 – – 7 3 – – 21 8 – – 10 4 – – 6 2
COPD/Asthma 1 85 25 72 21 203 59 192 56 89 26 76 22 79 23 76 22 177 52 163 48
2 255 75 80 23 129 38 70 20 213 62 91 27 214 63 88 26 143 42 81 24
3 2 1 94 27 10 3 52 15 40 12 87 25 49 14 105 31 22 6 74 22
4 – – 90 26 – – 19 6 – – 66 19 – – 60 18 – – 20 6
5 – – 6 2 – – 9 3 – – 22 6 – – 13 4 – – 4 1
Depression 1 165 66 154 62 205 82 204 82 119 48 113 45 107 43 82 33 46 18 33 13
2 84 34 54 22 44 18 21 8 118 47 72 29 121 48 88 35 175 70 89 36
3 1 0 24 10 1 0 21 8 13 5 37 15 22 9 48 19 29 12 80 32
4 – – 17 7 – – 4 2 – – 25 10 – – 24 10 – – 32 13
5 – – 1 0 – – 0 0 – – 3 1 – – 8 3 – – 16 6
Diabetes 1 189 68 179 64 232 83 231 83 172 61 162 58 129 47 115 42 189 68 173 62
2 89 32 53 19 47 17 36 13 95 34 69 25 135 49 93 34 87 31 71 26
3 0 0 26 9 0 0 8 3 13 5 28 10 13 5 41 15 3 1 25 9
4 – – 21 8 – – 4 1 – – 13 5 – – 23 8 – – 7 3
5 – – 0 0 – – 0 0 – – 6 2 – – 5 2 – – 1 0
Liver disease 1 457 74 465 73 542 88 568 89 425 68 428 68 367 60 365 58 346 56 347 55
2 163 26 103 16 73 12 42 7 183 29 106 17 233 38 151 24 249 40 166 26
3 1 0 53 8 3 0 21 3 14 2 69 11 15 2 94 15 22 4 97 15
4 – – 17 3 – – 4 1 – – 22 3 – – 19 3 – – 19 3
5 – – 1 0 – – 2 0 – – 6 1 – – 3 0 – – 5 1
Personality disorder 1 324 85 320 84 357 94 357 93 120 31 98 26 168 44 137 36 64 17 51 13
2 58 15 39 10 24 6 21 5 228 60 85 22 197 52 132 34 217 57 82 21
3 1 0 21 5 0 0 3 1 33 9 119 31 17 4 85 22 100 26 119 31
4 – – 2 1 – – 1 0 – – 70 18 – – 26 7 – – 105 27
5 – – 1 0 – – 0 0 – – 10 3 – – 3 1 – – 25 7
RA/Arthritis 1 106 29 83 22 235 64 223 60 106 29 81 22 45 12 26 7 222 60 190 51
2 263 71 115 31 132 36 84 23 232 63 131 36 282 76 123 33 134 36 100 27
3 0 0 101 27 3 1 43 12 32 9 94 25 43 12 135 37 14 4 54 15
4 – – 67 18 – – 17 5 – – 46 12 – – 73 20 – – 18 5
5 – – 3 1 – – 2 1 – – 17 5 – – 12 3 – – 7 2
Stroke 1 133 22 121 20 201 33 190 31 118 20 108 18 122 20 117 19 141 23 122 20
2 359 59 117 19 263 44 122 20 309 51 127 21 428 71 148 25 416 69 213 35
3 115 19 160 26 139 23 117 19 176 29 141 23 50 8 212 35 46 8 169 28
4 – – 113 19 – – 60 10 – – 95 16 – – 100 17 – – 79 13
5 – – 99 16 – – 118 19 – – 133 22 – – 26 4 – – 22 4
Students 1 434 98 428 97 442 100 442 442 398 90 376 85 297 67 268 60 246 56 190 43
2 9 2 12 3 1 0 0 1 44 10 48 11 145 33 143 32 192 43 173 39
3 0 0 2 0 0 0 1 0 1 0 15 3 1 0 29 7 5 1 55 12
4 – – 1 0 – – 0 0 – – 3 1 – – 3 1 – – 21 5
5 – – 0 0 – – 0 0 – – 1 0 – – 0 0 – – 4 1
  1. COPD chronic obstructive pulmonary disease, RA rheumatoid arthritis
Back to article page